PCI 7 November 2023, 15:22
Thermofisher: Thu 29 February 2024, 11:15
BMG Labtech: Wed 18 September 2024, 11:55
Owen Mumford 12 January 2022, 16:46

Current Edition

Cell and Gene Therapy

Upcoming Events

PEGS Boston – 17/02/2025
NextGen BioMed – 04/02/2025
BioTrinity 2025 – January 30th 2025
Elrig R&I 2025 – 27th January 2025
Biotechnology Show 2025: 20th January 2025
Anglonordic: 16th January 2025
AI in Drug Discovery – SAE media – January 14th 2025

Advertisement

Fujifilm rectangle: Fri 22 November 2024, 14:23
Roald Dahl Charity: Fri 15 November 2024, 12:57
A&M STABTEST: Fri 21 June 2024, 11:43
CDD Vault: Wed 17 July 2024, 11:46
Aurisco – 04/02/2025

Outcry over gene-edited babies grows as Chinese researcher defends work

 

  • He Jiankui, the Chinese researcher who stunned the scientific world with his claim of having genetically altered a set of twins born this month, defended his work Wednesday at an international genome editing summit in Hong Kong.
  • He’s presentation, however, appears to have done little to allay strong condemnation from other researchers in the field, who charge his work breaches ethical and scientific norms. Scrutiny of He’s research methods has also grown, with China’s National Health Commission requesting an investigation and institutions associated with He disavowing knowledgeof his work.
  • Addressing the summit, He said he’s “proud” of his work and pushed back against criticism that the genetic changes made using CRISPR/Cas9 — disabling the CCR5 gene to confer resistance to HIV infection — weren’t medically necessary. He also indicated another pregnancy involving an edited embryo had occurred.

Amid a storm of ethical criticism, the question of whether He accomplished exactly what he claims remains.

At the summit, He presented details of his research, including more information on the genetic sequencing he conducted before and after the birth of the twin girls, named Lulu and Nana.

He also said he submitted his work to a scientific journal for review, but didn’t indicate which one. Conference organizers introducing He at the summit indicated slides submitted by the researcher beforehand did not include mention of implanted human embryos.

The lack of transparency has strengthened accusations that He deliberately conducted his work in secret. Southern University of Science and Technology, where He works, said it had no knowledge of the research and that the work was conducted outside of its grounds.

A statement from the owners of Shenzhen Hospital, where He claimed to have received ethical approval, claims that signatures on an application to the institution’s ethics committee appear to be forged, according to a Bloomberg report.

“Foremost, that edited human babies were generated without the full engagement of independent scientific and ethics experts, relevant regulatory institutions, and governing bodies is appalling,” wrote David Liu, a professor at Harvard University heavily involved in genome editing research, in a statement.

Questions from attendees at the conference centered on how He obtained approval to proceed as well as how he secured informed consent from the participating parents-to-be.

He indicated he reviewed the informed consent process with about four people and said that he had previously consulted with visiting scientists and ethicists in the U.S.

Informed consent, always important, is particularly critical for gene editing studies given the uncertainty and risk for off-target effects and other unintended consequences.

More broadly, He’s study brings forward core ethical questions for the entire gene editing field — questions that will need to be addressed comprehensively and internationally to avoid the potential for catastrophic missteps.

“To successfully advance tools like Cas9 to improve health; we’ll need more than just laws to ensure these tools aren’t misused and abused,” Food and Drug Administration Commissioner Scott Gottlieb wrote on Twitter. “The scientific community must enforce without mercy strict standards on the moral and ethical limits of how these technologies should be used.”

Newcells 3 June 2024, 15:12
Novonordisk: Wed 17 July 2024, 11:22
FujiFilm 30 October 2023, 16:23
Autoscribe Mon 26 June 2023, 15:15
Aldevron: 16th January 2025
Richter: Wed 23 October 2024, 09:03
GenXPro: Mon 16 September 2024, 10:40